Logo image of PSIG

PS INTERNATIONAL GROUP LTD (PSIG) Stock Fundamental Analysis

NASDAQ:PSIG - Nasdaq - KYG7308J1058 - Common Stock - Currency: USD

0.421  -0.06 (-12.29%)

After market: 0.4241 +0 (+0.74%)

Fundamental Rating

0

We assign a fundamental rating of 0 out of 10 to PSIG. PSIG was compared to 22 industry peers in the Air Freight & Logistics industry. PSIG has a bad profitability rating. Also its financial health evaluation is rather negative. PSIG has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year PSIG has reported negative net income.
PSIG Yearly Net Income VS EBIT VS OCF VS FCFPSIG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 0 500K -500K -1M

1.2 Ratios

PSIG has a Return On Assets of -6.34%. This is in the lower half of the industry: PSIG underperforms 63.64% of its industry peers.
PSIG has a Return On Equity (-12.63%) which is in line with its industry peers.
Industry RankSector Rank
ROA -6.34%
ROE -12.63%
ROIC N/A
ROA(3y)-4.32%
ROA(5y)N/A
ROE(3y)-460.57%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
PSIG Yearly ROA, ROE, ROICPSIG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 0 -200 -400 -600 -800 -1K

1.3 Margins

PSIG does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
PSIG Yearly Profit, Operating, Gross MarginsPSIG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023

More info and screens

1

2. Health

2.1 Basic Checks

PSIG has less shares outstanding than it did 1 year ago.
The debt/assets ratio for PSIG is higher compared to a year ago.
PSIG Yearly Shares OutstandingPSIG Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2M 4M 6M 8M 10M
PSIG Yearly Total Debt VS Total AssetsPSIG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 20M 40M 60M 80M

2.2 Solvency

Based on the Altman-Z score of -0.16, we must say that PSIG is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of -0.16, PSIG is not doing good in the industry: 72.73% of the companies in the same industry are doing better.
PSIG has a Debt/Equity ratio of 0.11. This is a healthy value indicating a solid balance between debt and equity.
With a decent Debt to Equity ratio value of 0.11, PSIG is doing good in the industry, outperforming 68.18% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.11
Debt/FCF N/A
Altman-Z -0.16
ROIC/WACCN/A
WACCN/A
PSIG Yearly LT Debt VS Equity VS FCFPSIG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 0 20M 40M 60M 80M

2.3 Liquidity

A Current Ratio of 0.03 indicates that PSIG may have some problems paying its short term obligations.
The Current ratio of PSIG (0.03) is worse than 86.36% of its industry peers.
PSIG has a Quick Ratio of 0.03. This is a bad value and indicates that PSIG is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.03, PSIG is not doing good in the industry: 86.36% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.03
Quick Ratio 0.03
PSIG Yearly Current Assets VS Current LiabilitesPSIG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 500K 1M 1.5M 2M

More info and screens

0

3. Growth

3.1 Past

The earnings per share for PSIG have decreased strongly by -452.20% in the last year.
EPS 1Y (TTM)-452.2%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for PSIG. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
PSIG Price Earnings VS Forward Price EarningsPSIG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
PSIG Per share dataPSIG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.1 -0.1 0.2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for PSIG!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

PS INTERNATIONAL GROUP LTD

NASDAQ:PSIG (4/24/2025, 8:00:00 PM)

After market: 0.4241 +0 (+0.74%)

0.421

-0.06 (-12.29%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupTransportation
GICS IndustryAir Freight & Logistics
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.86%
Inst Owner Change0%
Ins Owners63.97%
Ins Owner ChangeN/A
Market Cap10.22M
AnalystsN/A
Price TargetN/A
Short Float %0.35%
Short Ratio0.05
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 1.76
P/tB 1.76
EV/EBITDA N/A
EPS(TTM)-0.18
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0
BVpS0.24
TBVpS0.24
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -6.34%
ROE -12.63%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-4.32%
ROA(5y)N/A
ROE(3y)-460.57%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.11
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.03
Quick Ratio 0.03
Altman-Z -0.16
F-ScoreN/A
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-452.2%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-73.69%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-11.66%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-11.66%
OCF growth 3YN/A
OCF growth 5YN/A